Derivative exercise or conversion — not an open-market buy.
Loading…
Traded Mar 16, 2026 · Filed Mar 17, 2026
TransDigm Group's Co-Chief Operating Officer sold $112K of TransDigm Group shares. Nobody planned it ahead of time.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$112,059
Shares × reported transaction price
41 days after results of Feb 3, 2026, 29 days before results of Apr 14, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $1,247.82 on Mar 16, 2026, within 3% of its 52-week low, after a 13% drop over the previous 30 trading days
52-week range $1,214.66 (Mar 13, 2026) to $1,620.83 (Jul 30, 2025), 8% of the way up, from 251 adjusted closes. 30 trading days earlier: $1,427.54 on Jan 30, 2026. Describes the past only, not a forecast
None found in footnotes
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | -3.6% | -0.7% | -2.9% |
| 30 days | +5.5% | +7.4% | -1.9% |
| 90 days | +8.4% | +13.4% | -5.0% |
| 180 days | -7.4% | +15.0% | -22.4% |
Past results only. Not a forecast.
Derivative exercise or conversion — not an open-market buy.
TransDigm Group's Co-Chief Operating Officer sold $297K of TransDigm Group shares. Nobody planned it ahead of time.
TransDigm Group's Co-Chief Operating Officer sold $153K of TransDigm Group shares. Nobody planned it ahead of time.